Authorized purpose: TAVIPILOT detects, tracks, and marks the non-coronary cusp and prosthetic valve on live fluoroscopy during specified adult femoral TAVR or TAVI procedures under physician control.
Clinical role
Image reconstruction, localization, navigation, or procedural guidance under direct professional control.
Images and patients
Fluoroscopy/Angiography · Heart/Cardiovascular
Key limitation
Keep in mind: It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: TAVIPILOT detects, tracks, and marks the non-coronary cusp and prosthetic valve on live fluoroscopy during specified adult femoral TAVR or TAVI procedures under physician control.
Which images or clinical context are in scope?Modality: Fluoroscopy/Angiography Anatomy or clinical context: Heart/Cardiovascular Input: User-selected valve type, valve size and positioning, plus a live fluoroscopic stream from an FDA-cleared X-ray system.
Who uses it?Intended users: A clinical specialist fully skilled and qualified to perform the TAVI/TAVR procedure, such as a cardiac/cardiothoracic surgeon or interventional cardiologist; users must complete training and certification before operation.
What does the software produce?Output: Raw fluoroscopic data with overlaid 2D guidance information, including 2D aortic-root-related landmarks and a 2D transcatheter aortic-valve overlay.
What is its most important limitation?Key limitation: It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
Clinical takeaway. Clinical role: TAVIPILOT detects, tracks, and marks the non-coronary cusp and prosthetic valve on live fluoroscopy during specified adult femoral TAVR or TAVI procedures under physician control.
Evidence takeaway. Evidence from the reviewed source record: K243884 reports multicenter, multivendor C-arm interoperability and patient-data performance validation for landmark and valve tracking.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
TAVIPILOT detects, tracks, and marks the non-coronary cusp and prosthetic valve on live fluoroscopy during specified adult femoral TAVR or TAVI procedures under physician control.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
User-selected valve type, valve size and positioning, plus a live fluoroscopic stream from an FDA-cleared X-ray system.
Exact FDA submission
Checked 2026-09-19
The exact workflow identifies valve inputs and live fluoroscopic data from a cleared X-ray system; it does not establish CT or ultrasound images as subject-device inputs.
Raw fluoroscopic data with overlaid 2D guidance information, including 2D aortic-root-related landmarks and a 2D transcatheter aortic-valve overlay.
Exact FDA submission
Checked 2026-09-19
The exact workflow describes the raw fluoroscopic display and overlaid landmarks and valve guidance; it does not establish generic measurements or navigation guidance beyond these overlays.
A clinical specialist fully skilled and qualified to perform the TAVI/TAVR procedure, such as a cardiac/cardiothoracic surgeon or interventional cardiologist; users must complete training and certification before operation.
Exact FDA submission
Checked 2026-09-19
The exact intended-user section names skilled and qualified TAVI/TAVR clinical specialists and requires training and certification; it does not establish technologists or generic procedural staff as intended users.
It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K243884 reports multicenter, multivendor C-arm interoperability and patient-data performance validation for landmark and valve tracking.
Sensitivity is not the primary endpoint for this acquisition, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary endpoint for this acquisition, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K243884 FDA performance package for TAVIPILOT
DesignManufacturer multicenter image-performance and multivendor C-arm interoperability validation
PopulationAdult femoral TAVR or TAVI fluoroscopy cases using specified compatible equipment
Scopeexact submission
Tested versionTAVIPILOT release cleared in K243884
IndependenceSponsor or vendor study
K243884
Manufacturer evidence submitted for clearance or approval; local clinical, technical, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K243884 by exact submission identifier. This does not exclude product-family or later safety information.
Public source
Exact FDA submission
Checked 2026-09-03
Exact-identifier review does not prove absence of all product-family safety signals.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: User-selected valve type, valve size and positioning, plus a live fluoroscopic stream from an FDA-cleared X-ray system.
Scope: Exact FDA submission. The exact workflow identifies valve inputs and live fluoroscopic data from a cleared X-ray system; it does not establish CT or ultrasound images as subject-device inputs.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Procedure-room hardware and software or a connected workstation with supported imaging equipment and accessories.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Raw fluoroscopic data with overlaid 2D guidance information, including 2D aortic-root-related landmarks and a 2D transcatheter aortic-valve overlay.
Scope: Exact FDA submission. The exact workflow describes the raw fluoroscopic display and overlaid landmarks and valve guidance; it does not establish generic measurements or navigation guidance beyond these overlays.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Raw fluoroscopic data with overlaid 2D guidance information, including 2D aortic-root-related landmarks and a 2D transcatheter aortic-valve overlay.
Scope: Exact FDA submission. The exact workflow describes the raw fluoroscopic display and overlaid landmarks and valve guidance; it does not establish generic measurements or navigation guidance beyond these overlays.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Only qualified physicians, technologists, or procedural staff trained for the specified intervention. should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: It does not replace the surgeon or interventional cardiologist and excludes prior TAVR or SAVR, non-femoral access, non-tricuspid native valves, specified implants, and patients under 21; use only compatible valves, delivery systems, pigtails, C-arms, and workstation configuration.
exact submission · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
The exact packet identifies fluoroscopy and FDA-cleared C-arm X-ray systems; it does not establish a general angiography modality label. Controlled directory display reconciled from exact FDA wording: Image-intensified fluoroscopic X-ray imaging from an interventional C-arm system. -> Fluoroscopy/Angiography.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
11Source classes checked
0Screened PubMed leads
5Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 0 PubMed and 5 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 5 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-03 - Exact FDA submission
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: CARA assists adult structural-heart and conduction-system procedure planning by segmenting preprocedural CT, visualizing cardiac chambers and conduction landmarks, and overlaying a reviewed three-dimensional roadmap on live fluoroscopy.
Authorized purpose: QFR (3.0) uses paired coronary X-ray angiographic DICOM acquisitions to calculate three-dimensional vessel and lesion measurements and pressure-drop quantification for interventional cardiologist or researcher review in patients with coronary artery disease.
Authorized purpose: Trinias is an interventional fluoroscopic X-ray system for diagnostic and interventional angiography, including cardiac, neurovascular, abdominal, peripheral, rotational, multipurpose, and whole-body radiographic or fluoroscopic procedures.
Modality
Fluoroscopy/Angiography
Anatomy
Heart, neurovascular, abdominal, peripheral vessels, and whole body
Authorized purpose: EchoNavigator R5.0 supports an interventionalist or surgeon during cardiovascular treatment by combining live X-ray and live echocardiographic information.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.